With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Maraviroc proved noninferior to efavirenz among treatment-naive patients but is still unlikely to see much use in this population. The FDA recently approved the CCR5 inhibitor maraviroc for ...

Purpose: The mechanism of action, pharmacology, pharmacokinetics, clinical efficacy, drug interactions, adverse effects, dosage and administration, cost, and role in therapy of maraviroc are reviewed.

We conducted two double-blind, placebo-controlled, phase 3 studies — Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 — with ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

The FDA approved maraviroc in 150 mg and 300 mg tablets as the newest treatment for adults with HIV, last month. Maraviroc is the first CCR-5 co-receptor antagonist, representing the first therapy in ...

Discover comprehensive details about Maraviroc, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Adding maraviroc to standard combined antiretroviral therapy (c-ART) does not seem to improve clinical outcomes for patients initiating treatment for advanced HIV infection. Findings from a ...

Maraviroc, an oral drug used to treat HIV infection, is safe and well-tolerated when taken daily as pre-exposure prophylaxis to prevent HIV infection by HIV-uninfected men who have sex with men at ...

Please provide your email address to receive an email when new articles are posted on . Adding maraviroc to a standard three-drug antiretroviral therapy regimen in patients with advanced HIV did not ...

Contraindicated in patients with severe kidney problems, who are taking St. John's wort, and hypersensitivity. Caution should be exercised in patients with history of low blood pressure, dizziness, ...

We conducted subanalyses of the combined results of the Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 studies to better ...